← Open Payments lookup

ISABEL ROSE: Open Payments

NPI 1316609548 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,717 in 142 payments from 40 companies in 2025. Trend: 2023 $2,202 · 2024 $5,909 · 2025 $3,717

Food & beverage: $3,717
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation18$372
AstraZeneca Pharmaceuticals LP12$342
PFIZER INC.13$319
Janssen Biotech, Inc.10$309
E.R. Squibb & Sons, L.L.C.5$148
Takeda Pharmaceuticals U.S.A., Inc.6$144
Gilead Sciences, Inc.2$133
BeOne Medicines USA, Inc.5$125
Immunocore Limited3$107
Genentech USA, Inc.5$107

Products named: RYBREVANT, Trodelvy, ENHERTU, KIMMTRAK, JEMPERLI, ZYNLONTA, BESREMI, KISQALI.

Industry payments across MD — which companies pay providers there.